ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array

Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint SmartFrame Array™ Version 1.1 SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has received FDA clearance for version 1.1 of its next generation SmartFrame Array Neuro Navi
Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint SmartFrame Array™ Version 1.1 SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has received FDA clearance for version 1.1 of its next generation SmartFrame Array Neuro Navi
Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint

ClearPoint Neuro: The New Neurosurgical Platform Of Choice (NASDAQ:CLPT)

ClearPoint Neuro, Inc. on LinkedIn: We are delighted to announce FDA Clearance and First-in-Human cases…

NDA for Diazepam Buccal Film Accepted by FDA for Seizure Cluster Treatment

ClearPoint Neuro (NasdaqCM:CLPT) Stock Forecast & Analyst Predictions - Simply Wall St

ClearPoint Neuro, Inc.

Journal of Neurosurgery Publication Demonstrates Distinct

FDA Clears Neurostimulation Device for Opioid Withdrawal Relief

ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System

Press Releases :: ClearPoint Neuro, Inc. (CLPT)

ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array™ Version 1.1

Recent contributors: Duke, Sarah Cannon, and the UA Center for the Study of Tobacco and Society - The Cancer Letter

ClearPoint Neuro Stock: Potential Inflection Point (NASDAQ:CLPT)

ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System :: ClearPoint Neuro, Inc. (CLPT)

ClearPoint Neuro (CLPT) Stock: Path To Neurological Navigation Platform